Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelina V Vaseva

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|November 15, 2012
Identification of p53 in mitochondriaAngelina V Vaseva, Ute M Moll
Current Opinion in Pediatrics|December 10, 2019
Targeting RAS in pediatric cancer: is it becoming a reality?Angelina V Vaseva, Marielle E Yohe
Biochimica Et Biophysica Acta|November 15, 2008
The mitochondrial p53 pathwayAngelina V Vaseva, Ute M Moll
Cell Cycle (Georgetown, Tex.)|May 5, 2009
The transcription-independent mitochondrial p53 program is a major contributor to nutlin-induced apoptosis in tumor cellsAngelina V Vaseva, Natalia D Marchenko, Ute M Moll
Cancer Drug Resistance (Alhambra, Calif.)|April 22, 2022
Approaches to identifying drug resistance mechanisms to clinically relevant treatments in childhood rhabdomyosarcomaSamson Ghilu, Christopher L Morton, Angelina V Vaseva, et al.
Cell|June 26, 2012
p53 opens the mitochondrial permeability transition pore to trigger necrosisAngelina V Vaseva, Natalie D Marchenko, Kyungmin Ji, et al.
Cancer Letters|September 29, 2009
Differential inhibition sensitivities of MET mutants to the small molecule inhibitor SU11274Yitzhak Zimmer, Angelina V Vaseva, Michaela Medová, et al.
The Journal of Biological Chemistry|September 25, 2003
Negative feedback at the level of nuclear receptor coregulation. Self-limitation of retinoid signaling by RIP140Kristina A White, Mark M Yore, Shannon L Warburton, et al.
Molecular Cancer Therapeutics|September 26, 2022
Sensitization to Ionizing Radiation by MEK Inhibition Is Dependent on SNAI2 in Fusion-Negative RhabdomyosarcomaNicole R Hensch, Kathryn Bondra, Long Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2010
Radiosensitization of epidermal growth factor receptor/HER2-positive pancreatic cancer is mediated by inhibition of Akt independent of ras mutational statusRandall J Kimple, Angelina V Vaseva, Adrienne D Cox, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|November 15, 2012
Identification of p53 in mitochondriaAngelina V Vaseva, Ute M Moll
Current Opinion in Pediatrics|December 10, 2019
Targeting RAS in pediatric cancer: is it becoming a reality?Angelina V Vaseva, Marielle E Yohe
Biochimica Et Biophysica Acta|November 15, 2008
The mitochondrial p53 pathwayAngelina V Vaseva, Ute M Moll
Cell Cycle (Georgetown, Tex.)|May 5, 2009
The transcription-independent mitochondrial p53 program is a major contributor to nutlin-induced apoptosis in tumor cellsAngelina V Vaseva, Natalia D Marchenko, Ute M Moll
Cancer Drug Resistance (Alhambra, Calif.)|April 22, 2022
Approaches to identifying drug resistance mechanisms to clinically relevant treatments in childhood rhabdomyosarcomaSamson Ghilu, Christopher L Morton, Angelina V Vaseva, et al.
Cell|June 26, 2012
p53 opens the mitochondrial permeability transition pore to trigger necrosisAngelina V Vaseva, Natalie D Marchenko, Kyungmin Ji, et al.
Cancer Letters|September 29, 2009
Differential inhibition sensitivities of MET mutants to the small molecule inhibitor SU11274Yitzhak Zimmer, Angelina V Vaseva, Michaela Medová, et al.
The Journal of Biological Chemistry|September 25, 2003
Negative feedback at the level of nuclear receptor coregulation. Self-limitation of retinoid signaling by RIP140Kristina A White, Mark M Yore, Shannon L Warburton, et al.
Molecular Cancer Therapeutics|September 26, 2022
Sensitization to Ionizing Radiation by MEK Inhibition Is Dependent on SNAI2 in Fusion-Negative RhabdomyosarcomaNicole R Hensch, Kathryn Bondra, Long Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2010
Radiosensitization of epidermal growth factor receptor/HER2-positive pancreatic cancer is mediated by inhibition of Akt independent of ras mutational statusRandall J Kimple, Angelina V Vaseva, Adrienne D Cox, et al.
Pageof 3